INNPF (InnoCan Pharma) Total Tax Payable : $0.00 Mil (As of Sep. 2024)

View and export this data going back to 2020. Start your Free Trial

What is InnoCan Pharma Total Tax Payable?

InnoCan Pharma's Total Tax Payable for the quarter that ended in Sep. 2024 was $0.00 Mil.

InnoCan Pharma Total Tax Payable Historical Data

The historical data trend for InnoCan Pharma's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InnoCan Pharma Total Tax Payable Chart

InnoCan Pharma Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Tax Payable

Get a 7-Day Free Trial

InnoCan Pharma Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Total Tax Payable	Get a 7-Day Free Trial															-	-	-	-	-

InnoCan Pharma Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

InnoCan Pharma Total Tax Payable Related Terms

Thank you for viewing the detailed overview of InnoCan Pharma's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

InnoCan Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » InnoCan Pharma Corp (OTCPK:INNPF) » Definitions » Total Tax Payable

Comparable Companies

Traded in Other Exchanges

IP4:Germany INNO:Canada

Address

1015, 926 - 5 Avenue SW, Calgary, AB, CAN, T2P 0N7

Website

https://www.innocanpharma.com

InnoCan Pharma Corp is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol with other pharmaceutical ingredients as well as the development and sale of CBD-integrated pharmaceuticals. Geographically, it derives a majority of its revenue from the United States.